Advertisement

American Journal of Clinical Dermatology

, Volume 2, Issue 5, pp 305–313 | Cite as

Tissue-Engineered Skin

Current Status in Wound Healing
  • Ysabel M. Bello
  • Anna F. Falabella
  • William H. Eaglstein
Review Article

Abstract

Tissue-engineered skin is a significant advance in the field of wound healing and was developed due to limitations associated with the use of autografts. These limitations include the creation of a donor site which is at risk of developing pain, scarring, infection and/or slow healing.

A number of products are commercially available and many others are in development. Cultured epidermal autografts can provide permanent coverage of large area from a skin biopsy. However, 3 weeks are needed for graft cultivation. Cultured epidermal allografts are available immediately and no biopsy is necessary. They can be cryopreserved and banked, but are not currently commercially available.

A nonliving allogeneic acellular dermal matrix with intact basement membrane complex (Alloderm®) is immunologically inert. It prepares the wound bed for grafting allowing improved cultured allograft ‘take’ and provides an intact basement membrane. A nonliving extracellular matrix of collagen and chondroitin-6-sulfate with silicone backing (Integra®) serves to generate neodermis.

A collagen and glycosaminoglycan dermal matrix inoculated with autologous fibroblasts and keratinocytes has been investigated but is not commercially available. It requires 3 to 4 weeks for cultivation. Dermagraft® consists of living allogeneic dermal fibroblasts grown on degradable scaffold. It has good resistance to tearing. An extracellular matrix generated by allogeneic human dermal fibroblasts (TransCyte™) serves as a matrix for neodermis generation.

Apligraf® is a living allogeneic bilayered construct containing keratinocytes, fibroblasts and bovine type I collagen. It can be used on an outpatient basis and avoids the need for a donor site wound. Another living skin equivalent, composite cultured skin (OrCel™), consists of allogeneic fibroblasts and keratinocytes seeded on opposite sides of bilayered matrix of bovine collagen. There are limited clinical data available for this product, but large clinical trials are ongoing. Limited data are also available for 2 types of dressing material derived from pigs: porcine small intestinal submucosa acellular collagen matrix (Oasis™) and an acellular xenogeneic collagen matrix (E-Z-Derm™). Both products have a long shelf life.

Other novel skin substitutes are being investigated. The potential risks and benefits of using tissue-engineered skin need to be further evaluated in clinical trials but it is obvious that they offer a new option for the treatment of wounds.

Keywords

Dermal Fibroblast Epidermolysis Bullosa Small Intestinal Submucosa Acellular Dermal Matrix Skin Substitute 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

Dr Anna Falabella and Dr William Eaglstein have received research grants from Novartis, Organogenesis, and Advanced Tissue Sciences.

References

  1. 1.
    Pomahac B., Svensjo T., Yao F., et al. Tissue engineering of skin. Crit Rev Oral Biol Med 1998; 9 (3): 333–344PubMedCrossRefGoogle Scholar
  2. 2.
    Eaglstein W.H., Iriondo M., Laszlo K. A composite skin substitute (graftskin) for surgical wounds: a clinical experience. Dermatol Surg 1995; 21 (10): 839–843PubMedCrossRefGoogle Scholar
  3. 3.
    Falanga V. Commentary: advances in wound care. Are we there yet? WOUNDS 2000; 12 (3): 51–52Google Scholar
  4. 4.
    Boyce S.T. Skin substitutes from cultured cells and collagen-GAG polymers. Med Biol Eng Comput 1998; 36 (6): 791–800PubMedCrossRefGoogle Scholar
  5. 5.
    Eaglstein W.H., Falanga V. Tissue engineering for skin: an update. J Am Acad Dermatol 1998; 39: 1007–1010PubMedCrossRefGoogle Scholar
  6. 6.
    Rheinwald J., Green H. Serial cultivation of strains of human epidermal keratinocytes: formation of keratinizing colonies from single cells. Cell 1975; 6: 331–344PubMedCrossRefGoogle Scholar
  7. 7.
    Green H., Kehinde O., Thomas J. Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proc Natl Acad Sci U S A 1979; 76 (11): 5665–5668PubMedCrossRefGoogle Scholar
  8. 8.
    O’Connor N.E., Mulliken J.B., Banks-Schlegel S., et al. Grafting of burns with cultured epithelium prepared from autologous epidermal cells. Lancet 1981; I: 75–78CrossRefGoogle Scholar
  9. 9.
    Hefton J.M., Caldwell D., Biozes D.G., et al. Grafting of skin ulcers with cultured autologous epidermal cells. J Am Acad Dermatol 1986; 14: 399–405PubMedCrossRefGoogle Scholar
  10. 10.
    Gallico G., O’Connor N., Compton C., et al. Permanent coverage of large burn wounds with autologous cultured human epithelium. N Engl J Med 1984; 311: 448–451PubMedCrossRefGoogle Scholar
  11. 11.
    Carter D., Lin A., Varghese M., et al. Treatment of junctional epidermolysis bullosa with epidermal autografts. J Am Acad Dermatol 1987; 17: 246–250PubMedCrossRefGoogle Scholar
  12. 12.
    Gallico G.G., O’Connor N.E., Compton C.C., et al. Cultured epithelial autografts for giant congenital nevi. J Plast Reconstr Surg 1989; 84 (1): 1–9CrossRefGoogle Scholar
  13. 13.
    Plott R., Brysk M., Newton R. A surgical treatment for vitiligo: autologous cultured epithelial grafts. J Dermatol Surg Oncol 1989; 15: 1161–1166PubMedGoogle Scholar
  14. 14.
    Premachandra D., Woodward B., Milton C., et al. Treatment of postoperative otorrhea by grafting of mastoid cavities with cultured autologous epidermal cells. Lancet 1990; I: 365–367CrossRefGoogle Scholar
  15. 15.
    Romangnoli G., De Luca M., Faranda F., et al. Treatment of posterior hypospadias by the autologous graft cultured urethral epithelium. N Engl J Med 1990; 323: 527–530CrossRefGoogle Scholar
  16. 16.
    Phillips T.J., Pachas W. Clinical trial of cultured autologous keratinocyte grafts in the treatment of long-standing pressure ulcers. WOUNDS 1994; 6 (4): 113–119Google Scholar
  17. 17.
    Pellegrini G., Traverso C., Franzi A., et al. Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium. Lancet 1997; 349: 990–993PubMedCrossRefGoogle Scholar
  18. 18.
    Hafemann B., Ensslen S., Erdmann C., et al. Use of collagen/elastin membrane for the tissue engineering of dermis. Burns 1999; 25: 373–384PubMedCrossRefGoogle Scholar
  19. 19.
    Heck E., Bergstresser P., Baxter C. Composite skin grafts: frozen dermal allografts support the engraftment and expansion of autologous epidermis. J Trauma 1985; 25: 106–112PubMedCrossRefGoogle Scholar
  20. 20.
    Cuono C., Langdon R., McGuire J. Use of cultured epidermal autografts and dermal allografts as skin replacements after burn injury. Lancet 1986; I: 1123–124CrossRefGoogle Scholar
  21. 21.
    Phillips T.J. Biologic skin substitutes. J Dermatol Surg Oncol 1993; 19 (8): 794–800PubMedGoogle Scholar
  22. 22.
    Hefton J., Madden M., Finkelstein J., et al. Grafting of burn patients with allografts of cultured epidermal cells. Lancet 1983; II: 428–430CrossRefGoogle Scholar
  23. 23.
    Madden M., Finkelstein J., Staiano-Coco L. Grafting of cultured allogeneic epidermis on second and third degree wounds on 26 patients. J Trauma 1986; 26: 955–962PubMedCrossRefGoogle Scholar
  24. 24.
    De Luca M., Albanese E., Bondanza S., et al. Multicenter experience in the treatment of burns with autologous and allogeneic cultured epithelium, fresh or preserved in a frozen state. Burns 1989; 15: 303–309PubMedCrossRefGoogle Scholar
  25. 25.
    Leigh I.M., Purkis P.E., Navsaria H.A., et al. Treatment of chronic venous ulcers with sheets of cultured allogeneic keratinocytes. Br J Dermatol 1987; 117: 591–597PubMedCrossRefGoogle Scholar
  26. 26.
    Phillips T.J., Gilchrest B.A. Cultured epidermal grafts in the treatment of leg ulcers. Adv Dermatol 1990; 5: 33–48PubMedGoogle Scholar
  27. 27.
    Phillips T.J., Kehinde O., Green H., et al. Treatment of skin ulcers with cultured epidermal allografts. J Am Acad Dermatol 1989; 21 (2 Pt 1): 191–199PubMedCrossRefGoogle Scholar
  28. 28.
    Duhra P., Blight A., Mountford E., et al. A randomized controlled trial of cultured keratinocyte allografts for chronic venous ulcers. J Dermatol Treat 1992; 3: 189–191CrossRefGoogle Scholar
  29. 29.
    Phillips T.J., Provan A., Colbert D., et al. A randomized single blind controlled study of cultured epidermal allografts in the treatment of split thickness skin graft donor sites. Arch Dermatol 1993; 129: 879–882PubMedCrossRefGoogle Scholar
  30. 30.
    McGuire J., Birchall N., Cuono C., et al. Successful engraftment of allogeneic keratinocytes in recessive dystrophic epidermolysis bullosa. Clin Res 1987; 35: 720aGoogle Scholar
  31. 31.
    Bolivar-Flores J., Poumian E., Marsch-Moreno M., et al. Use of cultured human epidermal keratinocytes for allografting burns and conditions for temporary banking of the cultured allografts. Burns 1990; 16: 3–8PubMedCrossRefGoogle Scholar
  32. 32.
    De Luca M., Albanese E., Cancedda R., et al. Treatment of leg ulcers with cryopreserved allogenic cultured epithelium. Arch Dermatol 1992; 128: 633–638PubMedCrossRefGoogle Scholar
  33. 33.
    Teepe R.G., Roseeuw D.I., Hermans J., et al. Randomized trial comparing cryopreserved cultured epidermal allografts with hydrocolloid dressings in healing chronic venous ulcers. J Am Acad Dermatol 1993; 29 (6): 982–988PubMedCrossRefGoogle Scholar
  34. 34.
    Arambula H., Sierra-Martinez E., Gonzalez-Aguirre N., et al. Frozen human epidermal allogeneic cultures promote rapid healing of facial dermabrasion wounds. Dermatol Surg 1999; 25: 708–712PubMedCrossRefGoogle Scholar
  35. 35.
    Wainwright D., Malden M., Luterman A., et al. Clinical evaluation of an acellular allograft dermal matrix in full-thickness burns. J Burn Care Rehabil 1996; 17: 124–136PubMedCrossRefGoogle Scholar
  36. 36.
    Achauer B.M., VanderKam V.M., Celikoz B., et al. Augmentation of facial soft-tissue defects with alloderm dermal graft. Ann Plast Surg 1998; 41: 503–507PubMedCrossRefGoogle Scholar
  37. 37.
    Burke J., Yannas I., Quinby W., et al. Successful use of physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann Surg 1981; 194: 413–428PubMedCrossRefGoogle Scholar
  38. 38.
    Heimbach D., Luterman A., Burke J., et al. Artificial dermis for major burns. A multi-center randomized clinical trial. Ann Surg 1988; 208 (3): 313–320PubMedCrossRefGoogle Scholar
  39. 39.
    Boyce S.T., Kagan R.J., Meyer N.A., et al. The 1999 clinical research award. Cultured skin substitutes combined with integra artificial skin to replace native skin autograft and allograft for the closure of excised full-thickness burns. J Burn Care Rehabil 1999; 20 (6): 453–461PubMedCrossRefGoogle Scholar
  40. 40.
    Boyce S.T., Christianson D.J., Hansbrough J.F. Structure of a collagen-GAG dermal skin substitute optimized for cultured human epidermal keratinocytes. J Biomed Mater Res 1988; 22 (10): 939–957PubMedCrossRefGoogle Scholar
  41. 41.
    Hansbrough J., Boyce S., Cooper M., et al. Burn wound closure with cultured autologous keratinocytes and fibroblasts attached to a collagen-glycosaminoglycan substrate. JAMA 1989; 262: 2125–2130PubMedCrossRefGoogle Scholar
  42. 42.
    Nanchahal J., Ward C.M. New grafts for old? A review of alternatives to autologous skin. Br J Plast Surg 1992; 45 (5): 354–363PubMedCrossRefGoogle Scholar
  43. 43.
    Boyce S.T., Medrano E.E., Abdel-Malek Z., et al. Pigmentation and inhibition of wound contraction by cultured skin substitutes with adult melanocytes after transplantation to athymic mice. J Invest Dermatol 1993; 100 (4): 360–365PubMedCrossRefGoogle Scholar
  44. 44.
    Cooper M., Hansbrough J., Spielvogel R., et al. In vivo optimization of a living dermal substitute employing cultured human fibroblasts on a biodegradable polyglycolic acid or polyglactin mesh. Biomaterials 1991; 12: 243–248PubMedCrossRefGoogle Scholar
  45. 45.
    Pollak R., Edington H., Jensen J., et al. A human dermal replacement for the treatment of diabetic foot ulcers. WOUNDS 1997; 9: 175–183Google Scholar
  46. 46.
    Hansbrough J. Status of cultured skin replacement. WOUNDS 1995; 7 (4): 130–136Google Scholar
  47. 47.
    Purdue G.F., Hunt J.L., Still Jr J.M., et al. A multicenter clinical trial of a biosynthetic skin replacement, Dermagraft-TC, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds. J Burn Care Rehabil 1997; 18 (1 Pt 1): 52–57PubMedCrossRefGoogle Scholar
  48. 48.
    Bell E., Ehrlich H., Buttle D., et al. Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science 1981; 211: 1052–1054PubMedCrossRefGoogle Scholar
  49. 49.
    Wilkins L., Watson S., Prosky S., et al. Development of a bilayered living skin construct for clinical applications. Biotechnol Bioeng 1994; 43: 747–756PubMedCrossRefGoogle Scholar
  50. 50.
    Falanga V. How to use Apligraf to treat venous ulcers. Skin Aging 1999 Feb: 30–36Google Scholar
  51. 51.
    Falanga V., Margolis D., Alvarez O., et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group [see comments]. Arch Dermatol 1998; 134 (3): 293–300PubMedCrossRefGoogle Scholar
  52. 52.
    Kirsner R., Falanga V., Fivenson D., et al. Clinical experience with a human skin equivalent for the treatment of venous leg ulcers: process and outcomes. WOUNDS 1999; 11 (6): 137–144Google Scholar
  53. 53.
    Eaglstein W.H., Alvarez O.M., Auletta M., et al. Acute excisional wounds treated with a tissue-engineered skin (Apligraf). Dermatol Surg 1999; 25 (3): 195–201PubMedCrossRefGoogle Scholar
  54. 54.
    Muhart M., McFalls S., Kirsner R.S., et al. Behavior of tissue-engineered skin: a comparison of a living skin equivalent, autograft, and occlusive dressing in human donor sites [see comments]. Arch Dermatol 1999; 135 (8): 913–918PubMedCrossRefGoogle Scholar
  55. 55.
    Falabella A., Schachner L., Valencia I., et al. The use of tissue engineered skin (Apligraf) to treat a newborn with epidermolysis bullosa. Arch Dermatol 1999; 135: 1219–1222PubMedCrossRefGoogle Scholar
  56. 56.
    Falabella A.F., Valencia I.C., Eaglstein W.H., et al. Tissue-engineered skin (Apligraf) in the healing of patients with epidermolysis bullosa wounds. Arch Dermatol 2000; 136 (10): 1225–1230PubMedCrossRefGoogle Scholar
  57. 57.
    Morgan J., Yarmush M. Bioengineered skin substitutes. Sci Med 1997 Jul/Aug: 6–15Google Scholar
  58. 58.
    Eisenberg M., Llewelyn D. Surgical management of hands in children with recessive dystrophic epidermolysis bullosa: use of allogeneic composite cultured skin grafts. Br J Plast Surg 1998; 51 (8): 608–613PubMedCrossRefGoogle Scholar
  59. 59.
    Brown-Etris M., Punchello M., Shields D. Final report on a study to evaluate porcine small intestinal submucosa as a covering for partial thickness wounds [abstract]. The Symposium on Advanced Wound Care; 2000 Apr 1–4; DallasGoogle Scholar
  60. 60.
    Limat A., Mauri D., Hunziker T. Successful treatment of chronic leg ulcers with epidermal equivalents generated from cultured autologous outer root sheath cells. J Invest Dermatol 1996; 107: 128–135PubMedCrossRefGoogle Scholar
  61. 61.
    Black A.F., Berthod F., L’Heureux N., et al. In vitro reconstruction of a human capillary-like network in a tissue- engineered skin equivalent. FASEB J 1998; 12 (13): 1331–1340PubMedGoogle Scholar
  62. 62.
    Schechner J., Nath A., Zheng L., et al. In vivo formation of complex microvessels lined by human endothelial cells in a immunodeficient mouse. Proc Natl Acad Sci U S A 2000; 97 (16): 9191–9196PubMedCrossRefGoogle Scholar
  63. 63.
    Supp D.M., Bell S.M., Morgan J.R., et al. Genetic modification of cultured skin substitutes by transduction of human keratinocytes and fibroblasts with platelet-derived growth factor-A. Wound Repair Regen 2000; 8 (1): 26–35PubMedCrossRefGoogle Scholar
  64. 64.
    Michel M., L’Heureux N., Pouliot R., et al. Characterization of a new tissue-engineered human skin equivalent with hair. In Vitro Cell Dev Biol Anim 1999; 35 (6): 318–326PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 2001

Authors and Affiliations

  • Ysabel M. Bello
    • 1
  • Anna F. Falabella
    • 1
    • 2
  • William H. Eaglstein
    • 1
  1. 1.Department of Dermatology and Cutaneous SurgeryUniversity of Miami School of MedicineMiamiUSA
  2. 2.Department of Dermatology and Cutaneous SurgeryVeteran Affairs Medical CenterMiamiUSA

Personalised recommendations